Siegfried News and Activities

Siegfried is a company listed under the stock ticker SGFEF (CH).

Siegfried has a direct presence in 2 countries.

They are in:

• Pharmaceuticals67%
• Biotechnology33%

Acquisition, funding and merger involving Siegfried.

• Siegfried has acquired Noramco (posted on May 6 2026).

View the org chart displaying its 58 main executives

Most searched biographies at Siegfried

• Marcel Imwinkelried, Chief Executive Officer
• Wolfram Carius, Director
• Karl Petersson, Director

Popular executive movements at Siegfried

• Christina Del Vecchio will join the company as Chief Legal Officer on Nov. 1, 2026  (posted on June 2 2026).
• Luca Dalla Torre, Chief Legal and Sustainability Officer, will leave the company on Nov. 1, 2026  (posted on June 2 2026).
• Reto Suter, Chief Financial Officer, will leave the company on Jul. 1, 2026  (posted on November 17 2025).

Click here to view some more movements at Siegfried

Create your alert
to follow the executive moves at Siegfried.

Siegfried has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Siegfried

• News Subscription - Siegfried
• News Subscription - Siegfried

Social media about Siegfried

• Siegfried on Wikipedia, Google News & Yahoo Finance
• Siegfried on LinkedIn, X (Twitter) & YouTube